The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2023

Filed:

Apr. 23, 2021
Applicant:

Slayback Pharma Llc, Princeton, NJ (US);

Inventors:
Assignee:

SLAYBACK PHARMA LLC, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/277 (2006.01); A61K 31/519 (2006.01); A61K 9/00 (2006.01); A61K 47/12 (2006.01); A61K 47/40 (2006.01); A61K 47/14 (2017.01); A61K 47/26 (2006.01); A61K 47/20 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/0053 (2013.01); A61K 9/08 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/20 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01);
Abstract

The present invention relates to liquid pharmaceutical compositions of tofacitinib or its pharmaceutically acceptable salts thereof, suitable for oral administration, that are stable under varying storage conditions for extended periods of time. The present invention also relates to methods of treating auto-immune disorders using the stable liquid pharmaceutical compositions of tofacitinib. A stable liquid pharmaceutical composition of tofacitinib according to the invention comprises of (a) tofacitinib at a concentration of about 1 mg/mL or more; (b) a pharmaceutically acceptable liquid vehicle; (c) at least one anti-oxidant; and (d) optionally one or more other pharmaceutically acceptable excipients.


Find Patent Forward Citations

Loading…